Complementary, alternative medicine integration into clinical cancer care needs to be individualized
the ONA take:
Researchers at the Abramson Cancer Center at the University of Pennsylvania’s Perelman School of Medicine conducted a survey-based study to determine what drives the use of complementary and alternative medicine (CAM) among cancer patients.
The researchers surveyed 969 patients from the institution’s thoracic, breast, and gastrointestinal medical oncology clinics.
The findings reveal that expectation of therapeutic benefits, patient-perceived barriers regarding cost and access, and opinions of patients’ physician and family members predict patients’ use of CAM.
These beliefs and attitudes varied by key socio-demographic factors such as sex, race, and education.
Proven effectiveness of CAM practices such as yoga and acupuncture continue to support the practice of integrative oncology, which merges complementary and alternative medicine with conventional medicine to improve patient outsomes.
The researchers conclude that patient education on CAM practices should be tailored to the individual patient when integrating them into clinical care.
A study to determine what drives the use of complementary and alternative medicine among cancer patients.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- High Symptom Burden With Polycythemia Vera Linked to QoL Impairment
- Bioimpedence Spectroscopy Improves Early Detection of Breast Cancer-Related Lymphedema in At-Risk Patients
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- MRD Negativity Associated With Prolonged Survival in Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Patient Navigation Reduces Delays in Diagnostic Resolution
- Fee-for-service Medicare Plans Linked to Improved Care During Last Year of Life
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|